VICTORIA AKINS: Open Payments
NPI 1750832390 · NEW MADRID, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$740 in 38 payments from 13 companies in 2025. Trend: 2023 $928 · 2024 $887 · 2025 $740
Food & beverage: $740
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $143 |
| Radius Health, Inc. | 5 | $90 |
| Viatris Specialty LLC | 5 | $88 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $78 |
| Lilly USA, LLC | 4 | $75 |
| ABBVIE INC. | 3 | $68 |
| Novo Nordisk Inc | 2 | $42 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $38 |
| Seqirus USA Inc | 1 | $31 |
| Dexcom, Inc. | 2 | $31 |
Products named: BREZTRI, YUPELRI, JARDIANCE, MOUNJARO, VRAYLAR, Tymlos, Ozempic, Kerendia.
Industry payments across MO — which companies pay providers there.
